Endo International Ordinary Shares reported $570.72M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Aerie Pharmaceuticals AERI:US $ 58.69M 1.5M
Amarin AMRN:US 145.72M 2.21M
Ani Pharmaceuticals ANIP:US $ 64.18M 12.7M
Biodelivery Sciences International BDSI:US $ 25.78M 7.8M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Coherus Biosciences CHRS:US $ 111.81M 138.59M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Endo International Ordinary Shares ENDP:US $ 570.72M 35.49M
Flexion Therapeutics FLXN:US $ 45.06M 2.67M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Hikma Pharmaceutical HIK:LN 873M 27M
Horizon Pharma HZNP:US $ 694.03M 191.61M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Lannett LCI:US $ 139.83M 30.31M
Ligand Pharmaceuticals LGND:US $ 38.94M 16.3M
Merk MRK:US $ 9905M 839M
Novartis NOVN:VX 9.82B 464M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Patterson Companies PDCO:US $ 1654.4M 129.96M
Perrigo Ordinary Shares PRGO:US $ 1107M 148.4M
Pfizer PFE:US $ 13063M 3998M
Phibro Animal Health PAHC:US $ 201.12M 9.52M
Revance Therapeutics RVNC:US $ 89.14M 5.83M
Supernus Pharmaceuticals SUPN:US $ 107.22M 10.5M
Teva Pharmaceutical TEVA:IT 3.33B 220M
Xeris Pharmaceuticals Inc XERS:US $ 34.69M 9.76M
Zoetis ZTS:US $ 1.31B 128M